Patents by Inventor Klaus P. Theobald

Klaus P. Theobald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BRIMONIDINE COMPOSITIONS FOR TREATING ERYTHEMA
    Publication number: 20120282346
    Abstract: The present invention is directed to a pharmaceutical composition including brimonidine tartrate in an amount from about 0.17 percent by weight to about 0.19 percent by weight in a pharmaceutically acceptable carrier such as a gel or cream. The invention also relates to a method of treating erythema in a patient with rosacea by administering the composition of the invention to the site of erythema on the skin of the patient.
    Type: Application
    Filed: July 12, 2012
    Publication date: November 8, 2012
    Inventors: Klaus P. Theobald, Christopher V. Powala
  • BRIMONIDINE COMPOSITIONS FOR TREATING ERYTHEMA
    Publication number: 20120040016
    Abstract: The present invention is directed to a pharmaceutical composition including brimonidine tartrate in an amount from about 0.17 percent by weight to about 0.19 percent by weight in a pharmaceutically acceptable carrier such as a gel or cream. The invention also relates to a method of treating erythema in a patient with rosacea by administering the composition of the invention to the site of erythema on the skin of the patient.
    Type: Application
    Filed: October 21, 2011
    Publication date: February 16, 2012
    Inventors: Klaus P. Theobald, Christopher V. Powala
  • Brimonidine Compositions for Treating Erythema
    Publication number: 20090061020
    Abstract: The present invention is directed to a pharmaceutical composition including brimonidine tartrate in an amount from about 0.17 percent by weight to about 0.19 percent by weight in a pharmaceutically acceptable carrier such as a gel or cream. The invention also relates to a method of treating erythema in a patient with rosacea by administering the composition of the invention to the site of erythema on the skin of the patient.
    Type: Application
    Filed: August 18, 2008
    Publication date: March 5, 2009
    Inventors: Klaus P. Theobald, Christopher V. Powala